Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/22/26 17:34 | 1/20/26 | ELVN | Health | Drug | Pharmaceutical Preparations | Lyssikatos Joseph P | CO | O | CHIEF SC | 4 | S.m | -4,374 | 25.73 | 0 | -170 | 903 | I | |||||||||||||||
1/22/26 17:33 | 1/20/26 | ELVN | Health | Drug | Pharmaceutical Preparations | Heyman Richard A. | CO | D | 2 | S.m | -381 | 25.16 | 0 | -15 | 173 | I | ||||||||||||||||
1/13/26 17:54 | 1/9/26 | ELVN | Health | Drug | Pharmaceutical Preparations | Patel Anish | CO | O | COO | 3 | S | -1,608 | 26.09 | 0 | -62 | 270 | I | |||||||||||||||
12/23/25 18:47 | 12/22/25 | ELVN | Health | Drug | Pharmaceutical Preparations | Hohl Benjamin | CO | O | CFO | 1 | M.d | 32 | 2.48 | 0 | 13 | 57 | 36 | D | ||||||||||||||
12/19/25 17:58 | 12/17/25 | ELVN | Health | Drug | Pharmaceutical Preparations | Kunkel Lori Anne | CO | D | 1 | M.d | 18 | 1.12 | 0 | 16 | 35 | 62 | D | |||||||||||||||
11/19/25 18:45 | 11/17/25 | ELVN | Health | Drug | Pharmaceutical Preparations | Kintz Samuel | CO | DO | P,CEO | 1 | S | -273 | 21.82 | 0 | -13 | 890 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |